Literature DB >> 25282042

In vivo tracking and immunological properties of pulsed porcine monocyte-derived dendritic cells.

Elisa Crisci1, Lorenzo Fraile2, Rosa Novellas3, Yvonne Espada3, Raquel Cabezón4, Jorge Martínez5, Lorena Cordoba1, Juan Bárcena6, Daniel Benitez-Ribas7, María Montoya8.   

Abstract

Cellular therapies using immune cells and in particular dendritic cells (DCs) are being increasingly applied in clinical trials and vaccines. Their success partially depends on accurate delivery of cells to target organs or migration to lymph nodes. Delivery and subsequent migration of cells to regional lymph nodes is essential for effective stimulation of the immune system. Thus, the design of an optimal DC therapy would be improved by optimizing technologies for monitoring DC trafficking. Magnetic resonance imaging (MRI) represents a powerful tool for non-invasive imaging of DC migration in vivo. Domestic pigs share similarities with humans and represent an excellent animal model for immunological studies. The aim of this study was to investigate the possibility using pigs as models for DC tracking in vivo. Porcine monocyte derived DC (MoDC) culture with superparamagnetic iron oxide (SPIO) particles was standardized on the basis of SPIO concentration and culture viability. Phenotype, cytokine production and mixed lymphocyte reaction assay confirmed that porcine SPIO-MoDC culture were similar to mock MoDCs and fully functional in vivo. Alike, similar patterns were obtained in human MoDCs. After subcutaneous inoculation in pigs, porcine SPIO-MoDC migration to regional lymph nodes was detected by MRI and confirmed by Perls staining of draining lymph nodes. Moreover, after one dose of virus-like particles-pulsed MoDCs specific local and systemic responses were confirmed using ELISPOT IFN-γ in pigs. In summary, the results in this work showed that after one single subcutaneous dose of pulsed MoDCs, pigs were able to elicit specific local and systemic immune responses. Additionally, the dynamic imaging of MRI-based DC tracking was shown using SPIO particles. This proof-of-principle study shows the potential of using pigs as a suitable animal model to test DC trafficking with the aim of improving cellular therapies.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DC tracking; Immunotherapy; MRI; Pig; Virus-like particles

Mesh:

Substances:

Year:  2014        PMID: 25282042     DOI: 10.1016/j.molimm.2014.08.006

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

Review 1.  Theranostic Nanoparticles for Tracking and Monitoring Disease State.

Authors:  Cristina Zavaleta; Dean Ho; Eun Ji Chung
Journal:  SLAS Technol       Date:  2017-11-08       Impact factor: 3.047

Review 2.  Image-guided dendritic cell-based vaccine immunotherapy in murine carcinoma models.

Authors:  Bin Wang; Chong Sun; Sijia Wang; Na Shang; Matteo Figini; Quanhong Ma; Shanzhi Gu; Daniele Procissi; Vahid Yaghmai; Guoxin Li; Andrew Larson; Zhuoli Zhang
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 3.  The Potential of Magnetic Nanoparticles for Diagnosis and Treatment of Cancer Based on Body Magnetic Field and Organ-on-the-Chip.

Authors:  Ali Alirezaie Alavijeh; Mohammad Barati; Meisam Barati; Hussein Abbasi Dehkordi
Journal:  Adv Pharm Bull       Date:  2019-08-01

Review 4.  In Vivo MRI Tracking of Tumor Vaccination and Antigen Presentation by Dendritic Cells.

Authors:  Jeff W M Bulte; Ali Shakeri-Zadeh
Journal:  Mol Imaging Biol       Date:  2021-09-28       Impact factor: 3.484

5.  Chimeric RHDV Virus-Like Particles Displaying Foot-and-Mouth Disease Virus Epitopes Elicit Neutralizing Antibodies and Confer Partial Protection in Pigs.

Authors:  Giselle Rangel; Juan Bárcena; Noelia Moreno; Carlos P Mata; José R Castón; Alí Alejo; Esther Blanco
Journal:  Vaccines (Basel)       Date:  2021-05-07

6.  Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses.

Authors:  Noelia Moreno; Ignacio Mena; Iván Angulo; Yolanda Gómez; Elisa Crisci; María Montoya; José R Castón; Esther Blanco; Juan Bárcena
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.